March 28, 2019 | Inside Healthy Policy
This article explores American Clinical Laboratory Association (ACLA) president and CEO Julie Khani’s desire to start a dialogue with FDA to refine aspects of a draft bill that would redefine the agency’s regulatory authority over diagnostics. Specifically, she hopes to work with the agency on revisions to the bill's provision involving precertification and modification of existing tests in order to make those concepts less burdensome for test makers. Aaron Josephson, a senior director at ML Strategies and former senior policy advisor at FDA’s device center, is among the industry sources quoted within the piece.
March 28, 2019 | Law360
Sean Prosser, a former U.S. Securities and Exchange Commission enforcement attorney, joined Mintz as a member of the litigation department to represent clients facing shareholder litigation and SEC and U.S. Department of Justice investigations and enforcement actions.
March 25, 2019 | The American Lawyer
Sean Prosser was the leader of Perkins Coie's white-collar, government investigations and securities litigation practices in Southern California before he joined Mintz.